221 related articles for article (PubMed ID: 25468225)
41. Demonstration of a brachytherapy boost dose-response relationship in glioblastoma multiforme: headed in the right direction.
Schultz CJ
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):187-8. PubMed ID: 8641918
[No Abstract] [Full Text] [Related]
42. Metallofullerene-nanoplatform-delivered interstitial brachytherapy improved survival in a murine model of glioblastoma multiforme.
Wilson JD; Broaddus WC; Dorn HC; Fatouros PP; Chalfant CE; Shultz MD
Bioconjug Chem; 2012 Sep; 23(9):1873-80. PubMed ID: 22881865
[TBL] [Abstract][Full Text] [Related]
43. Radioimmunotherapy of gastrointestinal cancer and glioblastomas.
Riva P; Tison V; Arista A; Sturiale C; Franceschi G; Riva N; Casi M; Moscatelli G; Campori F; Spinelli A
Int J Biol Markers; 1993; 8(3):192-7. PubMed ID: 8277212
[TBL] [Abstract][Full Text] [Related]
44. Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery.
Scoccianti S; Perna M; Olmetto E; Delli Paoli C; Terziani F; Ciccone LP; Detti B; Greto D; Simontacchi G; Grassi R; Scoccimarro E; Bonomo P; Mangoni M; Desideri I; Di Cataldo V; Vernaleone M; Casati M; Pallotta S; Livi L
Crit Rev Oncol Hematol; 2021 Jan; 157():103184. PubMed ID: 33307416
[TBL] [Abstract][Full Text] [Related]
45. Brachytherapy for brain tumor.
Suh JH; Barnett GH
Hematol Oncol Clin North Am; 1999 Jun; 13(3):635-50, viii-ix. PubMed ID: 10432434
[TBL] [Abstract][Full Text] [Related]
46. Surgically targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review.
Odia Y; Gutierrez AN; Kotecha R
Neuro Oncol; 2022 Nov; 24(Suppl 6):S16-S24. PubMed ID: 36322100
[TBL] [Abstract][Full Text] [Related]
47. Surviving Over a Decade With Glioblastoma: A Clinical Course Characterized by Multiple Recurrences, Numerous Salvage Treatments, and Novel Use of Cesium-131 Tiles.
Mehta S; Vassantachart AK; Fossum CC; Yang W; Shen ZL; Chang KE; Ye JC; Chen TC; Chang EL
Cureus; 2021 Nov; 13(11):e19573. PubMed ID: 34926045
[TBL] [Abstract][Full Text] [Related]
48. Role of Re-irradiation in Salvage Treatment of Glioblastoma Multiforme.
Cihan YB
Asian Pac J Cancer Prev; 2016; 17(5):2729-30. PubMed ID: 27268660
[No Abstract] [Full Text] [Related]
49. Radiation dose estimate to ocular lens in irradiation for glioblastoma multiforme.
Shin KH; O'Brien P; Geggie PH; Muller PJ; Arthur K
AJR Am J Roentgenol; 1980 Oct; 135(4):860-1. PubMed ID: 6255781
[No Abstract] [Full Text] [Related]
50. Extreme hypofractionation for newly diagnosed glioblastoma: rationale, dose, techniques, and outcomes.
Kotecha R; Mehta MP
Neuro Oncol; 2020 Aug; 22(8):1062-1064. PubMed ID: 32479631
[No Abstract] [Full Text] [Related]
51. Multifunctionalized Gold Sub-Nanometer Particles for Sensitizing Radiotherapy against Glioblastoma.
Dong CY; Hong S; Zheng DW; Huang QX; Liu FS; Zhong ZL; Zhang XZ
Small; 2021 Feb; 17(5):e2006582. PubMed ID: 33382206
[TBL] [Abstract][Full Text] [Related]
52. Glioblastoma multiforme: "who should receive stereotactic boost therapy?".
Mehta MP
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):746. PubMed ID: 7928514
[No Abstract] [Full Text] [Related]
53. State of the art: the evolving role of RT in combined modality therapy for GBM.
Bindra RS; Galanis E; Mehta MP
J Neurooncol; 2017 Sep; 134(3):477-478. PubMed ID: 28913783
[No Abstract] [Full Text] [Related]
54. New technique for removable implantation of radionuclides in central nervous system neoplasm by ultrasonic guidance.
Tsutsumi Y; Andoh Y; Matsutani M; Asai A
Surg Neurol; 1985 May; 23(5):520-4. PubMed ID: 2984797
[TBL] [Abstract][Full Text] [Related]
55. Combined modality approaches in the management of adult glioblastoma.
Shirazi HA; Grimm S; Raizer J; Mehta MP
Front Oncol; 2011; 1():36. PubMed ID: 22655242
[TBL] [Abstract][Full Text] [Related]
56. A Phase I/II Trial of 5 Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme.
Azoulay M; Ho CK; Fujimoto DK; Modlin LA; Gibbs IC; Hancock SL; Li G; Chang SD; Adler JR; Harsh GR; Nagpal S; Thomas R; Recht L; Choi CY; Soltys SG
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2S):E131-E132. PubMed ID: 27673859
[No Abstract] [Full Text] [Related]
57. Tissue factor at the crossroads of coagulation and radiation response in glioblastoma.
Mackman N; Tawil N; Rak J
J Thromb Haemost; 2024 Jan; 22(1):3-6. PubMed ID: 38173243
[No Abstract] [Full Text] [Related]
58. Radiotherapy in Glioblastoma: the Past, the Present and the Future.
Gzell C; Back M; Wheeler H; Bailey D; Foote M
Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):15-25. PubMed ID: 27743773
[TBL] [Abstract][Full Text] [Related]
59. Current medical treatment of glioblastoma.
Venur VA; Peereboom DM; Ahluwalia MS
Cancer Treat Res; 2015; 163():103-15. PubMed ID: 25468228
[TBL] [Abstract][Full Text] [Related]
60. Glioblastoma multiforme: Pathogenesis and treatment.
Alifieris C; Trafalis DT
Pharmacol Ther; 2015 Aug; 152():63-82. PubMed ID: 25944528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
